High materiality8/10
Ascendis Pharma (ASND) PT Raised to $312 at Oppenheimer
Why it may matterVerify against the original reporting
buy
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Oppenheimer raises ASND target to $312; current price $260.25.
- Target: $312; Current: $260.25; Firm: Oppenheimer
- Upside potential remains
Key facts
- 01
Target: $312
- 02
Posted price: $260.25
- 03
Analyst firm: Oppenheimer
- 04
Analyst: Leland Gershell
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.